AR018985A1 - Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retrovirales - Google Patents
Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retroviralesInfo
- Publication number
- AR018985A1 AR018985A1 ARP000101500A ARP000101500A AR018985A1 AR 018985 A1 AR018985 A1 AR 018985A1 AR P000101500 A ARP000101500 A AR P000101500A AR P000101500 A ARP000101500 A AR P000101500A AR 018985 A1 AR018985 A1 AR 018985A1
- Authority
- AR
- Argentina
- Prior art keywords
- infections
- pharmaceutical composition
- formula
- prevent hiv
- retroviral
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000031886 HIV Infections Diseases 0.000 title 1
- 206010038997 Retroviral infections Diseases 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000035415 Reinfection Diseases 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- 241001430294 unidentified retrovirus Species 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- LQIITQSGYNMPGU-UHFFFAOYSA-N 5-phenyl-1,2,4-thiadiazole Chemical compound C1=NSC(C=2C=CC=CC=2)=N1 LQIITQSGYNMPGU-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000005430 oxychloro group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Una composicion farmacéutica que detiene infecciones y reinfecciones en animales, particularmente en mamíferos, por VIH u otros retrovirus.La composicion comprende de 10 mg a 6000 mg, aproximadamente, de un derivado de (5-aril-1,2,4-tiadiazol)-3-il-tiourea o derivado de (5-aril-1,2,4-tia-diazol)-3-il de la formula (I). Tratamiento de infecciones y reinfecciones en animales, particularmente en mamíferos, por VIH u otrosretrovirus. Formula (I): en donde X es oxígeno o azufre, R es hidrogeno o alquilo que tiene C1-3, n es 0-4, R1 independientemente se selecciona delgrupo que consiste de hidrogeno, alquilo C1-7, cloro, bromo o fluor, oxicloro, alcoxi que tiene la formula O(CH2)yCH3 en donde y es de 1 a 6 o unasal de adicion farmacéutica o prodrogas de ésta. El compuesto preferido es (5-fenil-1,2,4-tiadiazol)-3-il tiourea.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28189599A | 1999-03-31 | 1999-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018985A1 true AR018985A1 (es) | 2001-12-12 |
Family
ID=23079222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000101500A AR018985A1 (es) | 1999-03-31 | 2000-03-31 | Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retrovirales |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6245788B1 (es) |
| EP (1) | EP1165074B1 (es) |
| JP (1) | JP2002540150A (es) |
| AR (1) | AR018985A1 (es) |
| AT (1) | ATE267598T1 (es) |
| AU (1) | AU763275B2 (es) |
| CA (1) | CA2368650C (es) |
| CO (1) | CO5160293A1 (es) |
| DE (1) | DE60011060T2 (es) |
| PE (1) | PE20001608A1 (es) |
| WO (1) | WO2000057869A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245788B1 (en) * | 1999-03-31 | 2001-06-12 | The Procter & Gamble Company | Viral treatment |
| EP1214931A1 (en) * | 2000-12-15 | 2002-06-19 | Schering Aktiengesellschaft | Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| US8629283B2 (en) * | 2008-03-06 | 2014-01-14 | Icahn School Of Medicine At Mount Sinai | Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof |
| WO2011150413A1 (en) * | 2010-05-28 | 2011-12-01 | Mount Sinai School Of Medicine | Antiviral compounds and uses thereof |
| US12356897B2 (en) * | 2020-04-14 | 2025-07-15 | Fluence Bioengineering, Inc. | Photoperiod manipulation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4353920A (en) | 1980-08-25 | 1982-10-12 | Olin Corporation | Use of selected 3-trihalomethyl-5-ureido-1,2,4-oxadiazoles and -1,2,4-thiadiazoles as agricultural viricides |
| JPS57136579A (en) * | 1981-01-21 | 1982-08-23 | Mitsui Toatsu Chem Inc | Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same |
| US4835168A (en) | 1985-12-16 | 1989-05-30 | Eli Lilly And Company | Thiadiazole antiviral agents |
| US5256680A (en) | 1988-11-29 | 1993-10-26 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents |
| US5593993A (en) | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
| IL102548A (en) | 1991-08-02 | 1998-08-16 | Medivir Ab | Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds |
| JPH06293651A (ja) * | 1993-04-07 | 1994-10-21 | Sapporo Breweries Ltd | Ｈｉｖ感染予防剤、ａｉｄｓ発症防止剤及びａｉｄｓ治療剤 |
| JPH07149748A (ja) * | 1993-09-30 | 1995-06-13 | Souyaku Gijutsu Kenkyusho:Kk | チアジアゾール誘導体及びその製造法 |
| JPH08169881A (ja) * | 1994-09-22 | 1996-07-02 | Soyaku Gijutsu Kenkyusho:Kk | アリールチアジアゾール誘導体及びそれを含有する抗ウイルス剤 |
| JPH08245384A (ja) * | 1995-03-13 | 1996-09-24 | Soyaku Gijutsu Kenkyusho:Kk | 抗ウイルス剤 |
| US6162791A (en) | 1998-03-02 | 2000-12-19 | Apotex Inc. | Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| US6258831B1 (en) * | 1999-03-31 | 2001-07-10 | The Procter & Gamble Company | Viral treatment |
| US6245788B1 (en) * | 1999-03-31 | 2001-06-12 | The Procter & Gamble Company | Viral treatment |
-
2000
- 2000-03-27 US US09/535,173 patent/US6245788B1/en not_active Expired - Fee Related
- 2000-03-29 WO PCT/US2000/008418 patent/WO2000057869A2/en not_active Ceased
- 2000-03-29 AU AU40488/00A patent/AU763275B2/en not_active Ceased
- 2000-03-29 DE DE60011060T patent/DE60011060T2/de not_active Expired - Lifetime
- 2000-03-29 AT AT00919867T patent/ATE267598T1/de not_active IP Right Cessation
- 2000-03-29 EP EP00919867A patent/EP1165074B1/en not_active Expired - Lifetime
- 2000-03-29 CA CA002368650A patent/CA2368650C/en not_active Expired - Fee Related
- 2000-03-29 JP JP2000607620A patent/JP2002540150A/ja active Pending
- 2000-03-31 CO CO00023491A patent/CO5160293A1/es unknown
- 2000-03-31 PE PE2000000286A patent/PE20001608A1/es not_active Application Discontinuation
- 2000-03-31 AR ARP000101500A patent/AR018985A1/es not_active Application Discontinuation
-
2001
- 2001-05-30 US US09/871,565 patent/US6384064B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2368650A1 (en) | 2000-10-05 |
| EP1165074A2 (en) | 2002-01-02 |
| US6245788B1 (en) | 2001-06-12 |
| AU4048800A (en) | 2000-10-16 |
| WO2000057869A2 (en) | 2000-10-05 |
| CO5160293A1 (es) | 2002-05-30 |
| US6384064B2 (en) | 2002-05-07 |
| PE20001608A1 (es) | 2001-02-08 |
| CA2368650C (en) | 2005-09-13 |
| DE60011060T2 (de) | 2004-10-14 |
| ATE267598T1 (de) | 2004-06-15 |
| DE60011060D1 (de) | 2004-07-01 |
| AU763275B2 (en) | 2003-07-17 |
| WO2000057869A3 (en) | 2001-04-26 |
| JP2002540150A (ja) | 2002-11-26 |
| EP1165074B1 (en) | 2004-05-26 |
| US20010034358A1 (en) | 2001-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR019505A1 (es) | Composicion farmaceutica y usos de la misma para tratar infecciones virales | |
| NO2022019I1 (no) | Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC | |
| DE69803750D1 (de) | Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften | |
| EA200200708A1 (ru) | Производные бензазола и их применение в качестве модуляторов jnk | |
| KR890016966A (ko) | 신규 항바이러스제 | |
| GT200000069A (es) | Derivados heterociclicos utiles como agentes anticancerosos. | |
| PA8493201A1 (es) | Uso de inhibidores de la sorbitol deshidrogenasa | |
| AU557691B2 (en) | 2-penem antibiotics and their oxa-aza-, and carba analogues | |
| ES2174992T3 (es) | Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales. | |
| DE60118590D1 (de) | Medizinische zusammensetzungen als begleittherapie gegen krebs | |
| CY1107899T1 (el) | 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας | |
| KR910004581A (ko) | 신규 화합물들 | |
| AR020851A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos | |
| AR019790A2 (es) | Compuestos derivados de la eritromicina, composiciones que los contienen. uso para preparar un medicamento | |
| BR9900565A (pt) | Inibidores de ciclooxigenase-2 de benzimidazol. | |
| AR012250A1 (es) | Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento | |
| KR910004591A (ko) | 헤테로 고리 화합물 | |
| BR0111780A (pt) | Agente herbicida | |
| AR018985A1 (es) | Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retrovirales | |
| HUT56809A (en) | Herbicidal composition comprising 2-(2', 3', 4'-trisubstituted benzoyl)-1,3-cyclohexanedione derivatives as active ingredient | |
| AR018706A1 (es) | Uso de una composicion farmaceutica para tratamiento de infecciones virales | |
| PT1468692E (pt) | Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma | |
| ATE45355T1 (de) | 5-(azolyloxyphenylcarbamoyl)barbitursaeurederivate als wirkstoffe fuer anthelmintika. | |
| NZ334701A (en) | Dihydropyrones and use in treating retrovirus infections and diseases | |
| KR910000684A (ko) | 소염제 페나메이트 1,3,4-티아디아졸 및 1,3,4-옥사디아졸 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |